FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $273,192 | -67.3% | 128,864 | -26.6% | 0.00% | -100.0% |
| Q2 2023 | $836,223 | -0.5% | 175,677 | +19.2% | 0.00% | 0.0% |
| Q1 2023 | $840,140 | -91.8% | 147,393 | -85.5% | 0.00% | -90.9% |
| Q4 2022 | $10,224,247 | -55.1% | 1,013,305 | -0.2% | 0.01% | -56.0% |
| Q3 2022 | $22,756,000 | -8.6% | 1,015,492 | +1.0% | 0.02% | -3.8% |
| Q2 2022 | $24,908,000 | -36.4% | 1,005,149 | -0.5% | 0.03% | -23.5% |
| Q1 2022 | $39,146,000 | -33.0% | 1,009,701 | +1.1% | 0.03% | +9.7% |
| Q4 2021 | $58,421,000 | -2.9% | 998,491 | -1.6% | 0.03% | -6.1% |
| Q3 2021 | $60,141,000 | -31.2% | 1,014,702 | +0.7% | 0.03% | -28.3% |
| Q2 2021 | $87,466,000 | +5.4% | 1,007,783 | +0.1% | 0.05% | +7.0% |
| Q1 2021 | $82,994,000 | +20.2% | 1,006,607 | +32.5% | 0.04% | +26.5% |
| Q4 2020 | $69,062,000 | +131.9% | 759,494 | +1.9% | 0.03% | +88.9% |
| Q3 2020 | $29,787,000 | +8.2% | 745,205 | -7.1% | 0.02% | -10.0% |
| Q2 2020 | $27,523,000 | +78.7% | 802,194 | +15.7% | 0.02% | +53.8% |
| Q1 2020 | $15,402,000 | -7.3% | 693,416 | -18.4% | 0.01% | +8.3% |
| Q4 2019 | $16,623,000 | +26.6% | 849,401 | +0.4% | 0.01% | +9.1% |
| Q3 2019 | $13,132,000 | -11.1% | 845,603 | +16.3% | 0.01% | -15.4% |
| Q2 2019 | $14,766,000 | +1180.7% | 727,365 | +1009.0% | 0.01% | +1200.0% |
| Q1 2019 | $1,153,000 | +63.5% | 65,587 | +19.3% | 0.00% | 0.0% |
| Q4 2018 | $705,000 | +73.2% | 54,979 | +120.1% | 0.00% | – |
| Q3 2018 | $407,000 | +8.2% | 24,978 | -24.8% | 0.00% | – |
| Q2 2018 | $376,000 | +116.1% | 33,196 | +86.1% | 0.00% | – |
| Q1 2018 | $174,000 | +152.2% | 17,842 | +58.9% | 0.00% | – |
| Q4 2017 | $69,000 | -38.4% | 11,230 | -60.6% | 0.00% | – |
| Q3 2017 | $112,000 | +100.0% | 28,467 | +130.1% | 0.00% | – |
| Q1 2017 | $56,000 | – | 12,372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |